Global Sarcopenia Supplement Market Size, Share and Trends Analysis Report, By Type (Protein Supplement, Vitamin B12 Supplement, Vitamin D & Calcium Supplement and Others), and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Forecast (2022-2028)

The sarcopenia supplement market is anticipated to grow at a significant CAGR of 5.1% during the forecast period (2022-2028). Sarcopenia is a term that refers to the loss of muscular mass, strength, and function that occurs at an elder age. There are currently no FDA-approved medicines for treating sarcopenia. Numerous research has looked at the benefits of exercise and nutritional supplements on sarcopenia patients. The market is expected to grow due to the rising prevalence of the geriatric population, as muscular weakness becomes more common as people become older. In older persons with sarcopenia, the risk of impairment is 1.5 to 4.6 times higher than in older adults without sarcopenia, as per the aging in motion organization.

The global sarcopenia supplement market is segmented based on type and distribution channel. Based on type, the market is sub-segmented into protein supplements, vitamin b12 supplements, vitamin d & calcium supplements, and others. Among these types, the protein supplement segment is expected to propel the growth of the market due to the added benefits of the protein supplements as it serves as a structural and functional compound in all organs and cells. Based on the distribution channel, the market is sub-segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

The market players are also contributing significantly to the market’s growth by adopting various strategies, including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, in March 2019, Element Nutrition, Inc., had launched Rejuvenate, a patented muscle health and repair supplement. It is a product, which is a blend of essential amino acids, that targets middle-aged individuals who may be dealing with age-related muscle and strength loss, known as sarcopenia. Rejuvenate supplementation boosted the strength of the knee and hip replacement patients recuperating from surgery by 800%, and helped patients on bed rest for 28 days grow muscle while those who did not take the supplement lost muscle. The powder is packaged in single-serve packets and may be readily combined with water.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape– Bayer AG, Zydus Cadila Inc., GlaxoSmithKline PLC, Nestle Health Science Inc., Sanofi SA, Eli Lilly and Co. Ltd., and Novartis International AG, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Sarcopenia Supplement Market Report by Segment

By Type

• Protein Supplement
• Vitamin B12 Supplement
• Vitamin D & calcium Supplement
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Sarcopenia Supplement Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa